| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 109.81B | 117.81B | 107.79B | 101.26B | 77.98B | 71.19B |
| Gross Profit | 25.57B | 27.82B | 25.41B | 22.87B | 17.42B | 15.76B |
| EBITDA | 19.65B | 21.59B | 19.47B | 17.75B | 13.35B | 12.16B |
| Net Income | 11.89B | 13.01B | 11.79B | 10.26B | 10.22B | 7.82B |
Balance Sheet | ||||||
| Total Assets | 83.43B | 97.44B | 90.48B | 86.41B | 68.16B | 63.27B |
| Cash, Cash Equivalents and Short-Term Investments | 28.62B | 34.91B | 30.36B | 29.42B | 38.37B | 31.82B |
| Total Debt | 1.51B | 0.00 | 1.93B | 3.38B | 200.95M | 281.12M |
| Total Liabilities | 19.70B | 22.64B | 22.23B | 22.37B | 12.70B | 11.43B |
| Stockholders Equity | 62.84B | 73.75B | 67.42B | 62.37B | 54.71B | 51.19B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 15.71B | 11.71B | 11.90B | 9.95B | 6.97B |
| Operating Cash Flow | 0.00 | 16.16B | 12.30B | 12.19B | 10.07B | 7.24B |
| Investing Cash Flow | 0.00 | -3.00B | 904.00M | -17.85B | 6.02B | -377.12M |
| Financing Cash Flow | 0.00 | -10.60B | -10.27B | -5.77B | -7.57B | -6.15B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥70.48B | 14.80 | 31.71% | 1.68% | 17.64% | 47.00% | |
76 Outperform | ¥29.39B | 10.67 | ― | 2.93% | 12.16% | 18.97% | |
75 Outperform | ¥191.07B | 16.08 | ― | 2.49% | 9.30% | 10.95% | |
74 Outperform | ¥45.91B | 12.58 | 8.02% | 2.73% | 5.82% | 16.78% | |
68 Neutral | ¥174.01B | 20.66 | 24.24% | ― | 16.80% | 27.73% | |
66 Neutral | ¥42.54B | 18.56 | ― | 1.50% | 10.69% | 6.99% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |